Metabolomics analysis identifies plasma metabolites linked to vascular access maturation, suggesting potential for personalized treatment.
Six metabolites identified in plasma samples collected prior to arteriovenous fistula creation were associated with subsequent vascular access maturation outcomes. If validated in larger studies, these biomarkers could aid personalized vascular access planning and inform research into potential novel therapeutic targets.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: